OpenURL Connection Search

Select item for more details and to access through your institution.

Evaluation of the Effects of Meal Type and Acid‐Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist.
Published in:
Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 677, doi. 10.1002/cpdd.1384
By:
- Weber, Elijah J.;
- Younis, Islam R.;
- Wang, Lulu;
- Xiao, Deqing;
- Barchuk, William T.;
- Othman, Ahmed A.
Publication type:
Article
Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical Trial.
Published in:
JAMA Ophthalmology, 2024, v. 142, n. 9, p. 789, doi. 10.1001/jamaophthalmol.2024.2439
By:
- Srivastava, Sunil K.;
- Watkins, Timothy R.;
- Nguyen, Quan Dong;
- Sharma, Sumit;
- Scales, David K.;
- Dacey, Mark S.;
- Shah, Rajiv E.;
- Chu, David S.;
- Grewal, Dilraj S.;
- Faia, Lisa J.;
- Suhler, Eric B.;
- Genovese, Mark C.;
- Guo, Ying;
- Barchuk, William T.;
- Besuyen, Robin;
- Dick, Andrew D.;
- Rosenbaum, James T.
Publication type:
Article
Safety and Efficacy of Poseltinib, Bruton's Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study.
Published in:
2021
By:
- Genovese, Mark C.;
- Spindler, Alberto;
- Akira Sagawa;
- Won Park;
- Dudek, Anna;
- Kivitz, Alan;
- Chao, Jeannie;
- Chan, Lai Shan Melanie;
- Witcher, Jennifer;
- Barchuk, William;
- Nirula, Ajay;
- Sagawa, Akira;
- Park, Won
Publication type:
journal article
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial.
Published in:
Rheumatology, 2022, v. 61, n. 6, p. 2388, doi. 10.1093/rheumatology/keab758
By:
- Maksymowych, Walter P;
- Østergaard, Mikkel;
- Landewé, Robert;
- Barchuk, William;
- Liu, Ke;
- Gilles, Leen;
- Hendrikx, Thijs;
- Besuyen, Robin;
- Baraliakos, Xenofon
Publication type:
Article
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
Published in:
Rheumatology, 2022, v. 61, n. 5, p. 2063, doi. 10.1093/rheumatology/keab543
By:
- Maksymowych, Walter P;
- Østergaard, Mikkel;
- Landewé, Robert;
- Barchuk, William;
- Liu, Ke;
- Tasset, Chantal;
- Gilles, Leen;
- Hendrikx, Thijs;
- Besuyen, Robin;
- Baraliakos, Xenofon
Publication type:
Article
A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-alpha antibody afelimomab in patients with sepsis syndrome.
Published in:
2001
By:
- Gallagher, James;
- Fisher, Charles;
- Sherman, Bruce;
- Munger, Mark;
- Meyers, Bruce;
- Ellison, Travis;
- Fischkoff, Steven;
- Barchuk, William T.;
- Teoh, Leah;
- Velagapudi, Raja;
- Gallagher, J;
- Fisher, C;
- Sherman, B;
- Munger, M;
- Meyers, B;
- Ellison, T;
- Fischkoff, S;
- Barchuk, W T;
- Teoh, L;
- Velagapudi, R
Publication type:
journal article
Toreforant, an orally active histamine H<sub>4</sub>-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study
Published in:
Inflammation Research, 2019, v. 68, n. 4, p. 261, doi. 10.1007/s00011-019-01218-y
By:
- Boyle, David L.;
- DePrimo, Samuel E.;
- Calderon, Cesar;
- Chen, Dion;
- Dunford, Paul J.;
- Barchuk, William;
- Firestein, Gary S.;
- Thurmond, Robin L.
Publication type:
Article
Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial.
Published in:
Clinical Infectious Diseases, 2004, v. 38, n. 2, p. 284, doi. 10.1086/379825
By:
- MacArthur, Rodger D.;
- Miller, Mark;
- Albertson, Timothy;
- Panacek, Edward;
- Johnson, David;
- Teoh, Leah;
- Barchuk, William
Publication type:
Article

Found: 8